Our CVRs are not going to be separately tradeable like that. Was that decision made because it could potentially be a huge distraction from ANIP pps ifLibigel was to be very successful?
Im thinking that Libigel news may be coming soon. Michael Snabes and S Simes have presented about Libigel at almost every ISSWSH cojference in recent past. Last years presentation was "Libigel Clear Path to Approval" AFTER efficacy issue. Susan Davis is the presenter. End of Feb.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.